The combination of mitragynine and morphine prevents the development of morphine tolerance in mice

Molecules

Volumn 18, Issue 1, 2013, Pages 666-681

  Fakurazi, Sharida ^a   Rahman, Shamima Abdul ^b   Hidayat, Mohamad Taufik ^a   Ithnin, Hairuszah ^a   Moklas, Mohamad Aris Mohd ^a   Arulselvan, Palanisamy ^a  

^a UNIVERSITY PUTRA MALAYSIA   (Malaysia)

^b CYBERJAYA UNIVERSITY COLLEGE OF MEDICAL SCIENCES   (Malaysia)

Author keywords

Antinociceptive; CAMP; Mitragyna speciosa; Morphine; Tolerance

Indexed keywords

ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; CREB1 PROTEIN, MOUSE; CYCLIC AMP; CYCLIC AMP RESPONSIVE ELEMENT BINDING PROTEIN; GAMMA GLUTAMYLTRANSFERASE; MITRAGYNINE; MORPHINE; NARCOTIC ANALGESIC AGENT; RAUWOLFIA ALKALOID;

ANIMAL; ARTICLE; BRAIN CORTEX; DRUG COMBINATION; DRUG EFFECT; DRUG SCREENING; DRUG TOLERANCE; ENZYMOLOGY; INSTITUTE FOR CANCER RESEARCH MOUSE; KIDNEY; LIVER; MALE; METABOLISM; MOUSE; NOCICEPTION; PHYSIOLOGY; THALAMUS;

ALANINE TRANSAMINASE; ANALGESICS, OPIOID; ANIMALS; ASPARTATE AMINOTRANSFERASES; CEREBRAL CORTEX; CYCLIC AMP; CYCLIC AMP RESPONSE ELEMENT-BINDING PROTEIN; DRUG EVALUATION, PRECLINICAL; DRUG THERAPY, COMBINATION; DRUG TOLERANCE; GAMMA-GLUTAMYLTRANSFERASE; KIDNEY; LIVER; MALE; MICE; MICE, INBRED ICR; MORPHINE; NOCICEPTION; SECOLOGANIN TRYPTAMINE ALKALOIDS; THALAMUS;

MLCS; MLOWN;

EID: 84872877076     PISSN: None     EISSN: 14203049     Source Type: Journal    
DOI: 10.3390/molecules18010666     Document Type: Article

References (48)

1. McDonald, J.; Lambert, D.G. Opioid mechanisms and opioid drugs. Anaesth. Intens. Care Med. 2008, 9, 33-37.
2. Angeles-López, G.; Pérez-Vásquez, A.; Hernández-Luis, F.; Déciga-Campos, M.; Bye, R.; Linares, E.; Mata, R. Antinociceptive effect of extracts and compounds from Hofmeisteria schaffneri. J. Ethnopharmacol. 2010, 131, 425-432.
3. Zhao, X.; Xu, Y.; Zhao, Q.; Chen, CR.; Liu, A.M.; Huang, Z.L. Curcumin exerts antinociceptive effects in a mouse model of neuropathic pain: descending monoamine system and opioid receptors are differentially involved. Neuropharmacology 2012, 62, 843-854.
4. Chee, J.W.; Amirul, A.A.; Majid, M.I.; Mansor, S.M. Factors influencing the release of Mitragyna speciosa crude extracts from biodegradable P(3HB-co-4HB). Int. J. Pharm. 2008, 361, 1-6.
5. Reanmongkol, W.; Keawpradub, N.; Sawangjaroen, K. Effects of the extracts from Mitragyna speciosa Korth. leaves on analgesic and behavioral activities in experimental animals. Songklanakarin. J. Sci. Technol. 2007, 29, 39-48.
6. Peter, J.H.; Ikram, M.S. 3-dehydromitragynine: An alkaloid from Mitragyna speciosa. Phytochemistry 1986, 25, 2910-2912.
7. Matsumoto, K.; Takayama, H.; Ishikawa, H.; Aimi, N.; Ponglux, D.; Watanabe, K.; Horie, S. Partial agonistic effect of 9-hydroxycorynantheidine on mu-opioid receptor in the guinea-pig ileum. Life Sci. 2006, 78, 2265-2271.
8. Takayama, H.; Ishikawa, H.; Kurihara, M.; Kitajima, M.; Aimi, N.; Ponglux, D.; Koyama, F.; Matsumoto, K.; Moriyama, T.; Yamamoto, L.T.; et al. Studies on the synthesis and opioid agonistic activities of mitragynine-related indole alkaloids: Discovery of opioid agonists structurally different from other opioid ligands. J. Med. Chem. 2002, 45, 1949-1956.
9. Takayama, H. Chemistry and pharmacology of analgesic indole alkaloids from the rubiaceous plant, Mitragyna speciosa. Chem. Pharm. Bull. (Tokyo) 2004, 52, 916-928.
10. Macko, E.; Weisbach, J.A.; Douglas, B. Some observations on the pharmacology of mitragynine. Archives Internationales de Pharmacodynamie et de Therapie 1972, 198, 145-151.
11. Jansen, K.L.R.; Prast, C. Ethnopharmacology of kratom and the Mitragyna alkaloids. J. Ethnopharmacol. 1988, 23, 115-119.
12. Matsumoto, K.; Mizowaki, M.; Suchitra, T.; Murakami, Y.; Takayama, H.; Sakai, S.; Aimi, N.; Watanabe, H. Central antinociceptive effects of mitragynine in mice: Contribution of descending noradrenergic and serotonergic systems. Eur. J. Pharmacol. 1996, 317, 75-81.
13. Matsumoto, K.; Mizowaki, M.; Suchitra, T.; Takayama, H.; Sakai, S.; Aimi, N.; Watanabe, H. Antinociceptive action of mitragynine in mice: Evidence for the involvement of supraspinal opioid receptors. Life Sci. 1996, 59, 1149-1155.
14. Yamamoto, L.T.; Horie, S.; Takayama, H.; Aimi, N.; Sakai, S.; Yano, S.; Shan, J.; Pang, P.K.; Ponglux, D.; Watanabe, K. Opioid receptor agonistic characteristics of mitragynine pseudoindoxyl in comparison with mitragynine derived from Thai medicinal plant Mitragyna speciosa. Gen. Pharmacol. 1999, 33, 73-81.
15. Shamima, A.R.; Fakurazi, S.; Hidayat, M.T.; Hairuszah, I.; Moklas, M.A.M.; Arulselvan, P. Antinociceptive Action of Isolated Mitragynine from Mitragyna Speciosa through Activation of Opioid Receptor System. Int. J. Mol. Sci. 2012, 13, 11427-11442.
16. Lauretti, G.R.; Lima, I.C.; Reis, M.P.; Prado, W.A.; Pereira, N.L. Oral ketamine and transdermal nitroglycerin as analgesic adjuvants to oral morphine therapy for cancer pain management. Anesthesiology 1999, 90, 1528-1533.
17. Mercadante, S. Opioid rotation for cancer pain: Rationale and clinical aspects. Cancer 1999, 86, 1856-1866.
18. White, P.F. The changing role of non-opioid analgesic techniques in the management of postoperative pain. Anesth. Analg. 2005, 101, S5-S22.
19. Sharma, S.K.; Nirenberg, M.; Klee, W.A. Morphine receptors as regulators of adenylate cyclase activity. Proc. Natl. Acad. Sci. USA 1975, 72, 590-594.
20. Brandt, M.; Fischer, K.; Moroder, L.; Wunsch, E.; Hamprecht, B. Enkephalin evokes biochemical correlates of opiate tolerance and dependence in neuroblastoma x glioma hybrid cells. FEBS Lett. 1976, 68, 38-40.
21. Boshart, M.; Weih, F.; Schmidt, A.; Fournier, R.E.; Schütz, G.A. Cyclic AMP response element mediates repression of tyrosine aminotransferase gene transcription by the tissue-specific extinguisher locus Tse-1. Cell 1990, 61, 905-916.
22. Meyer, T.E.; Habener, J.F. Cyclic adenosine 3',5'-monophosphate response element binding protein (CREB) and related transcription-Activating deoxyribonucleic acid-binding proteins. Endocr. Rev. 1993, 14, 269-290.
23. Sheng, M.; Thompson. M.A.; Greenberg, M.E. CREB: A Ca(2+)-regulated transcription factor phosphorylated by calmodulin-dependent kinases. Science 1991, 252, 1427-1430.
24. Widnell, K.L.; Russell, D.S.; Nestler, E.J. Regulation of expression of cAMP response elementbinding protein in the locus coeruleus in vivo and in a locus coeruleus-like cell line in vitro. Proc. Natl. Acad. Sci. USA 1994, 91, 10947-10951.
25. Coven, E.; Ni, Y.; Widnell, K.L.; Chen, J.; Walker, W.H.; Habener, J.F.; Nestler, E.J. Cell type-specific regulation of CREB gene expression: mutational analysis of CREB promoter activity. J. Neurochem. 1998, 71, 1865-1874.
26. Shaw-Lutchman, T.Z.; Barrot, M.; Wallace, T.; Gilden, L.; Zachariou, V.; Impey, S.; Duman, R.S.; Storm, D.; Nestler, E.J. Regional and cellular mapping of cAMP response element-mediated transcription during naltrexone-precipitated morphine withdrawal. J. Neurosci. 2002, 22, 3663-3672.
27. Chartoff, E.H.; Papadopoulou, M.; Konradi, C.; Carlezon, W.A., Jr. Dopamine-dependent increases in phosphorylation of cAMP response element binding protein (CREB) during precipitated morphine withdrawal in primary cultures of rat striatum. J. Neurochem. 2003, 87, 107-118.
28. Raffa, R.B. Pharmacology of oral combination analgesics: Rational therapy for pain. J. Clin. Pharm. Ther. 2001, 26, 257-264.
29. Du Pen, A.; Shen, D.; Ersek, M. Mechanisms of opioid-induced tolerance and hyperalgesia. Pain Manag. Nurs. 2007, 8, 113-121.
30. Wecker, L.; Crespo, L.M.; George, D.; Carl, F.; Stephanie, W. Brody's Human Pharmacology Molecular to Clinical; Mosby Elsevier: Philadelpia, PA, USA, 2010, pp. 74-78.
31. Nicholson, G.P. Treatment of anterior superior shoulder instability with a reverse ball and socket prosthesis. Oper. Technol. Orthop. 2003, 13, 235-241.
32. Noble, F.; Cox, B.M. Differential desensitization of mu- and delta-opioid receptors in selected neural pathways following chronic morphine treatment. Br. J. Pharmacol.1996, 117, 161-169.
33. Sim, L.J.; Selley, D.E.; Dworkin, S.I.; Childers, S.R. Effects of chronic morphine administration on mu opioid receptor-stimulated [35S] GTPgammaS autoradiography in rat brain. J. Neurosci. 1996, 16, 2684-2692.
34. Collier, H.O.; Francis, D.L. Morphine abstinence is associated with increased brain cyclic AMP. Nature 1975, 255, 159-162.
35. Nestler, E.J. Genes and addiction. Nat. Genet. 2000, 26, 277-281.
36. Matsumoto, K.; Horie, S.; Ishikawa, H.; Takayama, H.; Aimi, N.; Ponglux, D.; Watanabe, K. Antinociceptive effect of 7-hydroxymitragynine in mice: Discovery of an orally active opioid analgesic from the Thai medicinal herb Mitragyna speciosa. Life Sci. 2004, 74, 2143-2155.
37. Sim-Selley, L.J.; Selley, D.E.; Vogt, L.J.; Childers, S.R.; Martin, T.J. Chronic heroin self-Administration desensitizes mu opioid receptor-Activated G-proteins in specific regions of rat brain. J. Neurosci. 2000, 20, 4555-4562.
38. Yabaluri, N.; Medzihradsky, F. Down-regulation of mu-opioid receptor by full but not partial agonists is independent of G protein coupling. Mol. Pharmacol. 1997, 52, 896-902.
39. Nestler, E.J. Cellular responses to chronic treatment with drugs of abuse. Crit. Rev. Neurobiol. 1993, 7, 23-39.
40. Bilecki, W.; Przewlocki, R. Effect of opioids on Ca2+/cAMP responsive element binding protein. Acta Neurobiol. Exp. (Wars). 2000, 60, 557-567.
41. Bilecki, W.; Wawrzczak-Bargiela, A.; Przewlocki, R. Activation of AP-1 and CRE-dependent gene expression via mu-opioid receptor. J. Neurochem. 2004, 90, 874-882.
42. Beggs, S.; Micheal, WS. A straightjacket for pain- Cell 2010, 143, 505-507.
43. Jurgen, S. Understanding LTP in Pain Pathway. Mol. Pain 2007, 3, 100-106.
44. Simone, C.; Bosshard, C.B.; Matthias, T.; Wyss, T.M.; Bruno, W.; Markus, R. Assessment of Pain responses to innocuous and noxious electrical forepaw stimulation in mice using BOLD fMRI. Pain 2010, 655-663.
45. Guitart, X.; Thompson, M.A.; Mirante, C.K.; Greenberg, M.E.; Nestler, E.J. Regulation of cyclic AMP response element-binding protein (CREB) phosphorylation by acute and chronic morphine in the rat locus coeruleus. J. Neurochem. 1992, 58, 1168-1171.
46. Ozsoy-Sacan, O.; Yanardag, R.; Orak, H.; Ozgey, Y.; Yarat, A.; Tunali, T. Effects of parsley (Petroselinum crispum) extract versus glibornuride on the liver of streptozotocin-induced diabetic rats. J. Ethnopharmacol. 2006, 104, 175-181.
47. Singh, S.N.; Vats, P.; Suri, S.; Shyam, R.; Kumria, M.M.; Ranganathan, S.; Sridharan, K. Effect of an antidiabetic extract of Catharanthus roseus on enzymic activities in streptozotocin induced diabetic rats. J. Ethnopharmacol. 2001, 76, 269-277.
48. Mulder, G.J. Pharmaceutical Toxicology: Safety Sciences of Drugs; Dencker, L., Ed.; RPS Publishing: London, UK, 2000; pp. 137-160.